Personalized Melanoma Vaccine Breakthrough | Wilmington News

Wilmington News Today | 2 Min News | The Daily News Now! · Aug 21, 2026 · 1m

Merck and Moderna just dropped a game-changing update: their personalized melanoma vaccine, given after surgery, slashed cancer recurrence and spread in a massive trial—marking the first time mRNA therapy has proven effective in late-stage cancer. Using AI to decode each patient’s tumor, the vaccine trains the immune system to hunt down rogue cells with pinpoint accuracy. Results beat standard treatment, with fewer side effects—and researchers are already eyeing lung, bladder, and kidney cancers next. This could be the dawn of truly custom-fit cancer care. Listen in comfort:Get a discount on…